Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Approval of Stability Study Protocols – V 2.0

Posted on By

Creams: SOP for Approval of Stability Study Protocols – V 2.0

Standard Operating Procedure for Approval of Stability Study Protocols

Department Creams
SOP No. SOP/CRM/194/2025
Supersedes SOP/CRM/194/2022
Page No. Page 1 of 6
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for the approval of stability study protocols for cream products. Ensuring that stability studies are conducted according to approved protocols is critical to determining the shelf life and ensuring the quality and safety of the product over time.

2. Scope

This SOP applies to the approval of stability study protocols for all cream products under development, as well as those undergoing re-evaluation for market extension or regulatory submission. It ensures that stability studies are conducted according to regulatory requirements and internal standards.

3. Responsibilities

  • Research and Development (R&D) Team: Responsible for preparing the stability study protocol, including the selection of parameters, conditions, and test methods to be used in the study.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the stability study protocol to ensure it meets internal quality standards and regulatory requirements.
  • Regulatory Affairs Team: Responsible for ensuring that the stability study protocol complies with applicable regulatory guidelines
for product registration and submission.
  • Production Team: Responsible for providing necessary batch details and manufacturing conditions that are used in stability studies.
  • 4. Accountability

    The QA Manager is accountable for the approval process of stability study protocols. The R&D Manager is responsible for preparing the protocol, while the Regulatory Affairs Manager ensures compliance with relevant regulatory guidelines.

    5. Procedure

    5.1 Stability Study Protocol Preparation

    1. The R&D team prepares the stability study protocol, which should include:
      • The objective of the study
      • The product(s) to be tested (cream product name, batch number)
      • The testing conditions (e.g., temperature, humidity, light exposure)
      • The storage conditions (e.g., storage containers, packaging type)
      • The time points at which samples will be tested
      • The parameters to be tested (e.g., appearance, viscosity, pH, microbial load, packaging integrity)
      • The testing methods and specifications for each parameter
    2. The protocol should also define the expected duration of the study, based on the product’s intended shelf life and regulatory requirements.

    5.2 Protocol Review and Approval

    1. The completed protocol is submitted to the QA team for review.
    2. The QA team will verify that the stability study protocol complies with internal quality standards, industry best practices, and regulatory requirements. This includes checking the following:
      • Test parameters are appropriate for the product
      • Test methods are scientifically validated
      • Time points for testing are sufficient to assess product stability
      • Packaging and storage conditions are reflective of real-world conditions
    3. If the protocol meets all requirements, the QA team will approve the stability study protocol. If modifications are necessary, the protocol will be returned to the R&D team for revision.
    4. The approved protocol will be signed off by the QA Manager, R&D Manager, and Regulatory Affairs Manager.

    5.3 Regulatory Compliance Check

    1. The Regulatory Affairs team will review the stability study protocol to ensure that it meets the regulatory guidelines of the applicable markets (e.g., FDA, EMA).
    2. If the study is to be submitted to a regulatory body, the protocol must adhere to specific regulatory requirements for the stability testing of cosmetic or pharmaceutical products.
    3. The Regulatory Affairs team will provide a compliance report to the QA team after reviewing the protocol.

    5.4 Stability Study Execution

    1. Once the stability study protocol is approved, the R&D and Production teams will initiate the stability study according to the approved protocol.
    2. The stability study will be conducted over the designated time period, with testing performed at the specified time points.
    3. All testing results will be documented, and deviations from the protocol will be recorded and addressed according to internal deviation handling procedures.

    5.5 Documentation and Reporting

    1. Upon completion of the stability study, the results will be compiled into a final stability report, which will include:
      • A summary of the study conditions and methodology
      • The results of the testing at each time point
      • A comparison of the results with the predefined specifications
      • Any deviations or issues encountered during the study
      • Recommendations regarding the product’s shelf life and stability
    2. The stability report will be submitted to the QA team for review and approval.
    3. The final approved stability report will be archived and accessible for regulatory submissions, audits, and further analysis.

    5.6 Requalification of Stability Study Protocols

    1. If there are any changes to the formulation, manufacturing process, packaging, or storage conditions, the stability study protocol must be revised and re-qualified.
    2. The updated protocol will follow the same review and approval process as the original protocol, including QA, R&D, and Regulatory Affairs team evaluations.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QA: Quality Assurance
    • QC: Quality Control
    • SOP: Standard Operating Procedure
    • R&D: Research and Development
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Annexure-1: Stability Study Protocol Template
    2. Annexure-2: Stability Study Report Template
    3. Annexure-3: Regulatory Compliance Check Report

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q1A – Stability Testing of New Drug Substances and Products
    • FDA Guidance for Industry: Stability Testing of Drug Products

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Stability Study Protocol Template

    Study Objective Product Name Testing Conditions Test Methods Time Points
    To determine the shelf life of Vanilla Cream Vanilla Cream 25°C/60% RH Viscosity, pH, Microbial Load 0, 3, 6, 12 months

    Annexure-2: Stability Study Report Template

    Study Overview Testing Results Recommendations
    Summary of study conditions and methodology Viscosity: Pass, pH: Pass, Microbial Load: Pass Product shelf life: 12 months

    Annexure-3: Regulatory Compliance Check Report

    Regulatory Agency Regulatory Requirement Compliance Status Comments
    FDA Stability testing for 12 months Compliant Complies with FDA regulations

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Reviewing Validation Master Plans - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: Analytical Method Development: SOP for Analytical Method for Creams and Gels – V 2.0
    Next Post: SOP for Creating and Maintaining Technical Files for EU MDR Compliance

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version